15 September 2016 - Deborah Wilkes
Archived
Perrigo should focus on its "core" consumer healthcare businesses and consider divesting its "non-core" prescription pharmaceutical interests, according to investment firm Starboard Value.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.